Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review
Martina Amanzio, Dimos D. Mitsikostas, Fabio Giovannelli, et al.
The Lancet Regional Health - Europe (2021) Vol. 12, pp. 100253-100253
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 92
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Edoardo Caronna, Thomas C. van den Hoek, Hayrünnisa Bolay, et al.
Cephalalgia (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 32
Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination
Ingmar Schäfer, Jan Hendrik Oltrogge, Yvonne Nestoriuc, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e234732-e234732
Open Access | Times Cited: 23
Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders
Nathan T. M. Huneke, Guilherme Fusetto Veronesi, Matthew Garner, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 1
The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels
Aya Mohr‐Sasson, Jigal Haas, Shlomi Abuhasira, et al.
Human Reproduction (2021) Vol. 37, Iss. 3, pp. 534-541
Open Access | Times Cited: 47
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
Lanying Du, Yang Yang, Xiujuan Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 4, pp. 1054-1074
Open Access | Times Cited: 31
Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
Elisa Frisaldi, Aziz Shaibani, Fabrizio Benedetti, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e077243-e077243
Open Access | Times Cited: 15
Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review
Dimos D. Mitsikostas, Edoardo Caronna, Marina de Tommaso, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 5
Sharing online clinical notes with patients: implications for nocebo effects and health equity
Charlotte Blease
Journal of Medical Ethics (2022) Vol. 49, Iss. 1, pp. 14-21
Open Access | Times Cited: 22
Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review
Fátima Gauna, Jocelyn Raude, Charles Khouri, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Allergy-like nocebo events reported with COVID-19 vaccines: a case control study
Virginie Brès, Najah Ben Fadhel, Raphaël Trouillet, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
A Review of Recent Studies on the Effects of SARS-CoV-2 Infection and SARS-CoV-2 Vaccines on Male Reproductive Health
L.V. Adamyan, В.В. Елагин, V.I. Vechorko, et al.
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 18
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves
A. Doron, Yoav Piura, Ifat Vigiser, et al.
Journal of Neurology (2022) Vol. 269, Iss. 12, pp. 6193-6201
Open Access | Times Cited: 18
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
Juan Shi, Jian Zheng, Xiujuan Zhang, et al.
Translational research (2022) Vol. 248, pp. 11-21
Open Access | Times Cited: 17
Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies
Andreas Posa
Annals of Anatomy - Anatomischer Anzeiger (2025), pp. 152662-152662
Open Access
SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy
Adája E. Baars, Krista Kuitwaard, L.C. de Koning, et al.
Neurology (2022) Vol. 100, Iss. 2
Open Access | Times Cited: 16
Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis
Hye Jun Kim, Sang Jun Lee, Soonok Sa, et al.
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 3, pp. 356-365
Open Access | Times Cited: 8
Safety of Four COVID-19 Vaccines across Primary Doses 1, 2, 3 and Booster: A Prospective Cohort Study of Australian Community Pharmacy Vaccinations
Sandra Salter, Dani Li, Kevin M. Trentino, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2017-2017
Open Access | Times Cited: 14
Migraine worsening after COVID‐19 and COVID‐19 vaccination: Are we facing a nocebo effect?
Laura Melgarejo, Edoardo Caronna, Joana Rosell‐Mirmi, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3877-3885
Closed Access | Times Cited: 7
Nocebo affects after COVID-19 vaccination
Peter S. Sever
The Lancet Regional Health - Europe (2021) Vol. 12, pp. 100273-100273
Open Access | Times Cited: 18
Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs
Friederike L. Bender, Winfried Rief, Marcel Wilhelm
Vaccine (2022) Vol. 41, Iss. 2, pp. 294-303
Open Access | Times Cited: 12
Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies
Wen‐Hung Chung, Ivan Arni C. Preclaro, Wen‐Hung Chung, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1260-1260
Open Access | Times Cited: 11
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
Evrydiki Kravvariti, Maria‐Iosifina Kasdagli, Konstantina Maria Diomatari, et al.
Osteoporosis International (2023) Vol. 34, Iss. 3, pp. 585-598
Closed Access | Times Cited: 6
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis
Patrick DMC Katoto, Amanda Brand, Liliane N. Byamungu, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 10
Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients
Oliver Overheu, Simon Lendowski, Daniel R. Quast, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 1985-1992
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top